NCT05862090View on ClinicalTrials.gov

A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 5, 2023

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

RLD2301

Take it once a day per period.

DRUG

RLD2007

Take it once a day per period.

Trial Locations (1)

Unknown

Jeonbuk University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT05862090 - A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers | Biotech Hunter | Biotech Hunter